FLT3 inhibitors in the treatment of AML
Breakthroughs in the treatment of elderly patients with AML
Future therapies for AML: bispecifics and small molecule inhibitors
New drugs for CML: are more to come?
Bosutinib: a new, safer TKI for frontline CML